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This special issue reﬂects on multiple factors/mechanisms
involved in the pathogenesis of ALD. Alcoholic liver injury
is known to cause a broad range of liver abnormalities.
Alcohol is primarily metabolized in the hepatocyte leading
to increased secretion of inﬂammatory mediators, which, in
turn,activateand/orinﬂuencetheresponseofthenonparen-
chymal cells (NPCs) (hepatic stellate cells, Kupﬀer cells, and
sinusoidal endothelial cells) and subsequently control the
degree of liver injury.
This issue overviews general aspects of ALD, such
as oxidative stress and inﬂammation (A. Ambade and P.
Mandrekar) as well as the molecular aspects of these events,
including the role of ethanol-metabolizing enzymes, ADH
(T. Haseba et al.), and CYP2E1 (A. I. Cederbaum et al.) in
the development of alcohol-induced liver injury. In addition,
signaling mechanisms induced by alcohol are examined in
the paper by L. N. Gerjevic et al. As a separate pathogenic
aspect, the role of microRNA in ALD is analyzed in the paper
by S. Bala and G. Szabo.
The consequences of alcohol-related liver injury, such
as impairment of receptor-mediated endocytosis and lipid
droplet accumulation, are presented in experimental in vitro
studies of C. A. Casey et al. and B. McVicker et al., respec-
tively.
One of the mechanisms that aﬀects various liver cell
types and aﬀect disease progression is impairment of methy-
lation reactions. In our special issue, the role of impaired
methylation in pathogenesis of steatohepatitis as well as
treatment modalities with promethylating agent, betaine, is
discussed in the paper by C. H. Halsted and V. Medici and K.
Kharbanda et al.
Liver also serves as an immune organ and accommodates
a wide variety of cells, including immune cells. The latter
consistsofdendriticcells(DCs),naturalkiller(NK)cells,and
lymphocytes, which are present in normal livers. Selective
recruitment and retention of certain immune populations
occurs during diverse liver diseases, and these cells play
a critical role in the development and resolution of liver
inﬂammation, remodeling, and destruction and actively par-
ticipate in immune defense. The role of adaptive immunity
in ALD development is overviewed by E. Albano. Also, the
role of stem cells in ALD treatment is discussed in the paper
by M. Pai et al. Finally, to underline the role of alcohol in
progression of chronic infections (HCV), we included the
paper by M. Neuman et al. which reﬂects on the markers of
inﬂammation and ﬁbrosis in alcoholic hepatitis and hepatitis
C.
Each paper received external blind review in addition to
our reviews.
This special issue covers exciting new areas of ALD
pathogenesis and treatment and is strongly recommended
for the clinicians and basic scientists involved in alcohol re-
search.
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